Q-omics provides the consensus-scored VSIG10L2 profile across patient tissues and cancer cell-line models. Additionally, VSIG10L2 RNA expression shows 10,519 significant protein co-abundance associations, with the highest sampling consensus in BRCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for VSIG10L2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with VSIG10L2 in patient tissues and cancer cell lines. In patient samples, VSIG10L2 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set. In cancer cell lines, VSIG10L2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_SCLC.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	10,519	BRCA (4810)	view →
Function (mass-spec)	873	BRCA (401)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	487	LUNG_SCLC (192)	view →
Function (RNA)	132	LUNG_SCLC (83)	view →